Send feedback

CRYBA2 c.446+1G>A

VCV3893078

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 2 submitters
Consequence
canonical splice-site (±1/±2)
predicted LoF
gnomAD v4.1
Rare
ultra-rare (popmax 0.0407%, nfe)
Conditions
1
cataract 42

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation/SpliceAI carries the signal.
Consequencecanonical splice-site (±1/±2)predicted loss-of-function
Splicing
Splice regiondonor +1canonical splice dinucleotide (donor +1) · inside the BP7-excluded zone
SpliceAIΔ0.98donor loss · deltas
PangolinΔ0.76loss · gain 0.19 · agrees with SpliceAI · independent
Constraint at this position
ConservationphyloP 1.7GERP 0.9, phastCons 1
Overall
CADD24.6PHRED · no single calibrated threshold — expert panels disagree

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0407% European (non-Finnish) · 480/1,178,928 alleles
Filtering AF 0.0377% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0365%
Overall 0.0362% 584/1,612,740 alleles · ultra-rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.183% 548
Remaining individualsnot grpmax-eligible 0.0592% 1,688
European (non-Finnish)grpmax 0.0407% 2,456
Middle Eastern 0.0165% 6,054
African / African-American 0.0107% 9,377
Finnishnot grpmax-eligible 0.00312% 32,004
East Asian 0.00223% 44,818
South Asian 0.0011% 90,990

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CRYBA2
Coding
c.446+1G>A
MANE Select
NM_057093
Type
single nucleotide variant
Location
chr2:218990851 (GRCh38)
Gene constraint
LOEUF 1.372 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 93.12
Full CRYBA2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

cataract 42 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Early onset non-syndromic cataract (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, X-linked recessive
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cryba2-c-446-plus-1g-a (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown